CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
The (1)H, (13)C and (15)N nuclear magnetic resonance (NMR), Fourier transform infrared spectroscopy (FT-IR) and gas chromatography coupled to mass spectrometry (GC-MS) identification of a synthetic cannabinoid compound has been conducted. It was shown that this compound cannot be reliably distinguished from the closely related quinolin-8-yl indole-3-carboxylic acid derivative by an automatic search in MS library. Structural difference of the studied compound and known illicit compounds has been determined using 1D and 2D NMR spectroscopy. Analytical data for the identification of this compound were provided.